XBIO
Xenetic Biosciences, Inc.
+0.16 (+7.08%)2.35USD456K成交股數5.5M市值–本益比(近四季)1.7股價營收比+12.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 661K+12% | 807K+36% | 766K+25% | 1.0M+41% | 590K+15% | 593K-12% | 614K+1% | 726K+12% | 511K | 672K | 611K | 651K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 552K | 661K | 773K | 756K | 657K | 879K | 368K | 934K | 944K | 976K | 1.0M | 903K |
| 銷售管理費用 | 1.1M | 648K | 616K | 815K | 658K | 657K | 746K | 1.1M | 835K | 952K | 737K | 946K |
| 營業利益 | −972K+34% | −502K-47% | −623K+25% | −545K-59% | −724K-43% | −942K-25% | −499K-56% | −1.3M+12% | −1.3M | −1.3M | −1.1M | −1.2M |
| 營業利益率 | -147.1% | -62.2% | -81.3% | -53.0% | -122.8% | -158.9% | -81.3% | -184.1% | -248.3% | -186.9% | -187.6% | -184.1% |
| 稅後淨利 | −930K+35% | −456K-49% | −579K+33% | −510K-60% | −689K-42% | −903K-23% | −437K-59% | −1.3M+21% | −1.2M | −1.2M | −1.1M | −1.1M |
| 淨利率 | -140.7% | -56.6% | -75.6% | -49.7% | -116.7% | -152.2% | -71.1% | -175.4% | -234.0% | -174.3% | -172.7% | -161.4% |
| 稀釋 EPS | -0.41-9% | -0.20-66% | -0.21-25% | -0.33-60% | -0.45-42% | -0.59-23% | -0.28-59% | -0.83+20% | -0.78 | -0.77 | -0.69 | -0.69 |
| 稀釋股數 | 2.3M | 2.3M | 1.7M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 6.5M | 7.3M | 7.9M | 4.1M | 4.8M | 5.2M | 6.8M | 7.3M | 7.8M | 9.0M | 9.8M | 10.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 7.0M | 7.9M | 8.4M | 5.1M | 5.4M | 5.8M | 8.0M | 9.0M | 9.4M | 10.6M | 12.0M | 12.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 895K | 958K | 968K | 1.1M | 903K | 668K | 1.0M | 1.6M | 716K | 810K | 1.1M | 871K |
| 股東權益 | 6.1M | 7.0M | 7.4M | 4.0M | 4.5M | 5.1M | 7.0M | 7.4M | 8.7M | 9.8M | 10.9M | 11.9M |
| 負債比 | 12.8% | 12.1% | 11.6% | 21.9% | 16.9% | 11.5% | 12.5% | 17.6% | 7.6% | 7.6% | 8.9% | 6.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −536K-46% | – | – | – | −1.0M | – | – | −1.2M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2021 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2021 年度 · 1.2M
| Royalty | 1.2M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.0M | +19.0% | −2.7M | -90.1% | -1.58 | – |
| FY2024 | 2.5M | -1.6% | −4.0M | -158.4% | -2.57 | – |
| FY2023 | 2.5M | +48.8% | −4.1M | -162.8% | -2.71 | – |
| FY2022 | 1.7M | +47.1% | −6.6M | -383.9% | -4.61 | – |
| FY2021 | 1.2M | +165.6% | −5.6M | -486.4% | -0.55 | – |
| FY2020 | 437K | +2460.3% | −10.9M | -2,493.1% | -1.70 | – |
| FY2019 | 17K | – | −12.8M | -74,856.6% | -6.33 | – |
| FY2018 | 0 | – | −7.3M | –% | -9.66 | −6.5M |